MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$74,737K
Net loss
-$73,333K
(-27.69%↓ Y/Y)
Unrealized gain (loss) on
short-term investments
-$1,404K
Interest and other
income, net
$5,826K
(-26.06%↓ Y/Y)
Loss before income
taxes
-$73,325K
(-28.18%↓ Y/Y)
Income tax expense
$8K
(-96.46%↓ Y/Y)
Total other income,
net
$5,490K
(-26.77%↓ Y/Y)
License And
Collaboration Revenue
$12,499K
Product
$5,766K
Interest expense
$336K
(-12.04%↓ Y/Y)
Loss from operations
-$78,815K
(-21.82%↓ Y/Y)
Total revenue
$18,265K
(29.47%↑ Y/Y)
Total operating
expenses
$97,080K
(23.19%↑ Y/Y)
Research and development
$65,263K
(16.60%↑ Y/Y)
Selling, general and
administrative
$31,555K
Cost of product sales
$262K
Back
Back
Income Statement
source: myfinsight.com
Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA)